Trial intelligence / Profile preview

BIOxHEAL in Nonhealing Diabetic Foot Ulcers

NCT07852338Phase 3Recruiting

Sponsor
Applied Biologics
Start
Oct 2026
Primary completion
Sep 2027
Countries
1
01

Overview

A Phase 3 trial of BIOxHEAL in diabetic foot ulcer (DFU), sponsored by Applied Biologics. Started Oct 2026; status: recruiting.

02

Drugs

BIOxHEAL
03

Conditions

diabetic foot ulcer (DFU)

Beyond the preview

Go deeper on NCT07852338.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07852338.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call